Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease


Thinking about the time. Credit: Freeimages.com

Researchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzheimer's disease (AD). In a paper, "Proteomics of brain, CSF, and blood identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease," published in Science Translational Medicine, the researchers identify specific and shared proteomic changes associated with sporadic Alzheimer's disease (AD) across brain tissue, cerebrospinal fluid (CSF), and blood.

The findings show the potential of proteomic analysis to distinguish between different types of AD and act as a predictive model and biomarker of disease types. 

Original article

 


 

 

Comments

Popular posts from this blog

Research finds resin that destroys coronavirus on plastic surfaces

Study discovers cellular activity that hints recycling is in our DNA

Engineered Rabies Virus Illuminates Neural Circuitry